Literature DB >> 11145907

Effect of mutations in Gag on assembly of immature human immunodeficiency virus type 1 capsids in a cell-free system.

A R Singh1, R L Hill, J R Lingappa.   

Abstract

Studies of HIV-1 capsid formation in a cell-free system revealed that capsid assembly occurs via an ordered series of assembly intermediates and requires host machinery. Here we use this system to examine 12 mutations in HIV-1 Gag that others studied previously in intact cells. With respect to capsid formation, these mutations generally produced the same phenotype in the cell-free system as in cells, indicating the cell-free system's high degree of fidelity. Analysis of assembly intermediates reveals that a mutation in the distal region of CA (322 LDeltaS) and truncations proximal to the second cys-his box in NC block multimerization of Gag at early stages in the cell-free capsid assembly pathway. In contrast, mutations in the region of amino acids 56-68 (located in the proximal portion of MA) inhibit assembly at a later point in the pathway. Other mutations, including truncations distal to the first cys-his box in NC and mutations in the distal half of MA (88HDeltaG, 85YDeltaG, Delta104-115, and Delta115-129), do not affect formation of immature capsids in the cell-free system. These data provide new information on the role of different domains in Gag during the early events of capsid assembly. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145907     DOI: 10.1006/viro.2000.0706

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Intracellular targeting of Gag proteins of the Drosophila telomeric retrotransposons.

Authors:  S Rashkova; A Athanasiadis; M-L Pardue
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 2.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

3.  HIV Gag-leucine zipper chimeras form ABCE1-containing intermediates and RNase-resistant immature capsids similar to those formed by wild-type HIV-1 Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Motoko Tanaka; Veronica T Nguyen; Samina Giri; Jaisri R Lingappa
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

4.  Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells.

Authors:  Christopher M Owens; Peter C Yang; Heinrich Göttlinger; Joseph Sodroski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.

Authors:  Bridget A Robinson; Jonathan C Reed; Clair D Geary; J Victor Swain; Jaisri R Lingappa
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  Gag proteins of Drosophila telomeric retrotransposons: collaborative targeting to chromosome ends.

Authors:  Adelaide M Fuller; Elizabeth G Cook; Kerry J Kelley; Mary-Lou Pardue
Journal:  Genetics       Date:  2009-12-21       Impact factor: 4.562

7.  Intracellular targeting of telomeric retrotransposon Gag proteins of distantly related Drosophila species.

Authors:  Elena Casacuberta; Fernando Azorín Marín; Mary-Lou Pardue
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-04       Impact factor: 11.205

8.  Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro.

Authors:  Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag.

Authors:  Michael Sakalian; Stephanie S Dittmer; A Dustin Gandy; Nathan D Rapp; Ales Zábranský; Eric Hunter
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Host-rabies virus protein-protein interactions as druggable antiviral targets.

Authors:  Usha F Lingappa; Xianfu Wu; Amanda Macieik; Shao Feng Yu; Andy Atuegbu; Michael Corpuz; Jean Francis; Christine Nichols; Alfredo Calayag; Hong Shi; James A Ellison; Emma K T Harrell; Vinod Asundi; Jaisri R Lingappa; M Dharma Prasad; W Ian Lipkin; Debendranath Dey; Clarence R Hurt; Vishwanath R Lingappa; William J Hansen; Charles E Rupprecht
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.